Literature DB >> 29519500

Prediction and clinical implications of portal vein/superior mesenteric vein invasion in patients with resected pancreatic head cancer: the significance of preoperative CT parameters.

M Kim1, T W Kang2, D I Cha3, Y K Kim3, S H Kim3, K-T Jang4, I W Han5, I Sohn6.   

Abstract

AIM: To determine the preoperative computed tomography (CT) parameters that predict portal vein/superior mesenteric vein (PV-SMV) invasion in patients with pancreatic head cancer, and to assess whether PV-SMV invasion affects patient survival.
MATERIALS AND METHODS: Sixty patients with PV-SMV invasion, and 60 randomly selected patients without it, who had undergone preoperative CT and subsequent surgery for pancreatic head cancer were enrolled. The following CT parameters were evaluated using multivariate logistic regression and receiver operating characteristic analyses to predict vessel invasion (tumour size and margin, length of involved vessel, distance from the tumour to the vessel, vessel irregularity, the teardrop sign, and tumour-vein interface [TVI]). The Cox proportional hazard model was used to evaluate the effects of PV-SMV invasion on survival.
RESULTS: In multivariate analysis, tumour size (odds ratio [OR]=1.99) and TVI (OR=3.79 [≤90°], 20.66 [>90°, ≤180°], and 47.24 [>180°]) were independent CT predictors of PV-SMV invasion (p<0.05); they achieved a sensitivity of 87%, a specificity of 75%, and an accuracy of 81%; however, PV-SMV invasion did not affect patient survival after surgery (p=0.374).
CONCLUSION: In patients with pancreatic head cancer, preoperative CT parameters can predict PV-SMV invasion with high accuracy. PV-SMV invasion did not affect treatment outcome after surgery.
Copyright © 2018 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 29519500     DOI: 10.1016/j.crad.2018.01.016

Source DB:  PubMed          Journal:  Clin Radiol        ISSN: 0009-9260            Impact factor:   2.350


  5 in total

1.  MDCT findings predicting post-operative residual tumor and survival in patients with pancreatic cancer.

Authors:  Jae Seok Bae; Jung Hoon Kim; Ijin Joo; Won Chang; Joon Koo Han
Journal:  Eur Radiol       Date:  2019-03-21       Impact factor: 5.315

2.  Should the Splenic Vein Be Preserved-Fate of Sinistral Portal Hypertension after Pancreatoduodenectomy with Vascular Re-Section for Pancreatic Cancer.

Authors:  Sung Hyun Kim; Seung-Seob Kim; Ho Kyoung Hwang; Woo Jung Lee; Chang Moo Kang
Journal:  Cancers (Basel)       Date:  2022-10-04       Impact factor: 6.575

3.  Pancreatoduodenectomy without Vascular Resection in Patients with Primary Resectable Adenocarcinoma and Unilateral Venous Contact: A Matched Case Study.

Authors:  Luca Morelli; Raffaella Berchiolli; Simone Guadagni; Matteo Palmeri; Niccolò Furbetta; Desirée Gianardi; Matteo Bianchini; Niccola Funel; Giovanni Caprili; Luca Emanuele Pollina; Giulio Di Candio; Franco Mosca; Gregorio Di Franco; Alfred Cuschieri
Journal:  Gastroenterol Res Pract       Date:  2018-11-25       Impact factor: 2.260

4.  Borderline-resectable pancreatic adenocarcinoma: Contour irregularity of the venous confluence in pre-operative computed tomography predicts histopathological infiltration.

Authors:  Georgios A Kaissis; Fabian K Lohöfer; Sebastian Ziegelmayer; Julia Danner; Carsten Jäger; Rebekka Schirren; Donna Ankerst; Güralp O Ceyhan; Helmut Friess; Ernst J Rummeny; Wilko Weichert; Rickmer F Braren
Journal:  PLoS One       Date:  2019-01-02       Impact factor: 3.240

5.  CA19-9 Level to Serum γ-Glutamyltransferase as a Potential Prognostic Biomarker in Patients with Pancreatic Head Carcinoma.

Authors:  Shao-Cheng Lyu; Jing Wang; Mengxiu Huang; Han-Xuan Wang; Lin Zhou; Qiang He; Ren Lang
Journal:  Cancer Manag Res       Date:  2021-06-21       Impact factor: 3.989

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.